SCHEMBL4144658

SCHEMBL4144658

COC(=O)[C@H](Cc1ccccc1)NC(=O)Cc1ccc(O)cc1

nearest known ligand 0.70

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MDM4 O15151 1/20 0.70
MDM2 Q00987 1/20 0.70
TSHR P16473 1/20 0.66
ATM Q13315 1/20 0.58
CHRNA1 P02708 2/20 0.58
CHRNG P07510 2/20 0.58
CHRNB1 P11230 2/20 0.58
CHRND Q07001 2/20 0.58
ALDH1A1 P00352 2/20 0.57
MEN1 O00255 1/20 0.57
LMNA P02545 1/20 0.57
KMT2A Q03164 1/20 0.57
THRB P10828 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
HSD17B10 Q99714 1/20 0.56
HDAC1 Q13547 4/20 0.56
HDAC6 Q9UBN7 4/20 0.56
LNPEP Q9UIQ6 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13819237 1.00 MDM4 (0.70) MDM4MDM2TSHRATMCHRNA1
SCHEMBL4144661 1.00 MDM4 (0.70) MDM4MDM2TSHRATMCHRNA1
SCHEMBL4164846 1.00 MDM4 (0.70) MDM4MDM2TSHRATMCHRNA1
SCHEMBL4157633 0.94 MDM4 (0.64) MDM4MDM2TSHRALDH1A1KMT2A
SCHEMBL13819236 0.94 MDM4 (0.64) MDM4MDM2TSHRALDH1A1KMT2A
SCHEMBL4156603 0.93 ATM (0.65) MDM4MDM2ATMALDH1A1MEN1
SCHEMBL4156601 0.93 ATM (0.65) MDM4MDM2ATMALDH1A1MEN1
SCHEMBL13588075 0.91 MDM4 (0.63) MDM4MDM2TSHRATMCHRNA1
SCHEMBL10745859 0.91 TSHR (0.62) MDM4MDM2TSHRCHRNA1CHRNG
SCHEMBL3927422 0.90 MDM4 (0.57) MDM4MDM2TSHRCHRNA1CHRNG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112384495-B Novel modulators of metabotropic and ion-channel transmembrane receptors and uses thereof IBD治疗学有限责任公司 2023-07-18 CN claimed
EP-3792247-A1 NOVEL MODULATOR OF METABOTROPIC AND IONOTROPIC TRANSMEMBRANE RECEPTORS AND USE THEREOF IBD Therapeutics LLC (RU) 2021-03-17 EP claimed
US-20210070692-A1 NOVEL MODULATOR OF METABOTROPIC AND IONOTROPIC TRANSMEMBRANE RECEPTORS AND USE THEREOF IBD THERAPEUTICS LLC (RU) 2021-03-11 US claimed
CN-112384495-A Novel modulators of metabolic and ion channel transmembrane receptors and uses thereof IBD治疗学有限责任公司 2021-02-19 CN claimed
EP-1876169-B1 PHENYL-CONTAINING N-ACYL AMINE AND AMINOACID DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF, A PHARMACEUTICAL COMPOSITION AND THE USE THEREOF OBSCHESTVO S OGRANICHENNOI OTVETSTENNOSTIYU PHARMENTPR (RU) 2015-12-30 EP claimed
US-8309766-B2 Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof Obschestvo S. Organichennoi Otvetstvennostiyu Pharmenterprises (RU) 2012-11-13 US claimed
US-20090111874-A1 Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU PHARMENTERPRISES (RU) 2009-04-30 US claimed
EP-1876169-A1 PHENYL-CONTAINING N-ACYL AMINE AND AMINOACID DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF, A PHARMACEUTICAL COMPOSITION AND THE USE THEREOF Obschestvo S Ogranichennoi Otvetstennostiyu "Pharmenterprises" (RU) 2008-01-09 EP claimed
CN-112384495-B Novel modulators of metabotropic and ion-channel transmembrane receptors and uses thereof IBD治疗学有限责任公司 2023-07-18 CN disclosed
US-11414377-B2 Modulator of metabotropic and ionotropic transmembrane receptors and use thereof IBD THERAPEUTICS LLC (RU) 2022-08-16 US disclosed
EP-3792247-A1 NOVEL MODULATOR OF METABOTROPIC AND IONOTROPIC TRANSMEMBRANE RECEPTORS AND USE THEREOF IBD Therapeutics LLC (RU) 2021-03-17 EP disclosed
US-20210070692-A1 NOVEL MODULATOR OF METABOTROPIC AND IONOTROPIC TRANSMEMBRANE RECEPTORS AND USE THEREOF IBD THERAPEUTICS LLC (RU) 2021-03-11 US disclosed
EP-1876169-B1 PHENYL-CONTAINING N-ACYL AMINE AND AMINOACID DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF, A PHARMACEUTICAL COMPOSITION AND THE USE THEREOF OBSCHESTVO S OGRANICHENNOI OTVETSTENNOSTIYU PHARMENTPR (RU) 2015-12-30 EP disclosed
US-8309766-B2 Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof Obschestvo S. Organichennoi Otvetstvennostiyu Pharmenterprises (RU) 2012-11-13 US disclosed
US-20090111874-A1 Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU PHARMENTERPRISES (RU) 2009-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11414377-B2 Modulator of metabotropic and ionotropic transmembrane receptors and use thereof TRPM8, TRPV1, TRPA1 MDM4 4294/4885MDM2 3187/4885TSHR 951/4885
US-20210070692-A1 NOVEL MODULATOR OF METABOTROPIC AND IONOTROPIC TRANSMEMBRANE RECEPTORS AND USE THEREOF TRPM8, TRPV1, TRPA1 MDM4 4354/4885MDM2 3258/4885TSHR 1065/4885
US-20090111874-A1 Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof PAH, MAOA, APEH MDM4 4681/4885MDM2 4424/4885TSHR 3914/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.